Action P09 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Pacific Biosciences of California, Inc. BOERSE MUENCHEN

Actions

P09

US69404D1081

Temps réel BOERSE MUENCHEN
Autres places de cotation
 13:26:43 03/07/2024 		Varia. 5j. Varia. 1 janv.
1,196 EUR +1,56 % Graphique intraday de Pacific Biosciences of California, Inc. -9,97 % -87,43 %
27/06 PacBio et Form Bio s'associent pour lancer des initiatives visant à unifier l'industrie de la thérapie génique AAV MT
27/06 Form Bio et Pacbio annoncent leur collaboration pour lancer de nouvelles ressources destinées à transformer les meilleures pratiques en matière de conception et d'analyse des AAV CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
PacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
PR
Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
PR
Pacific Biosciences of California : PacBio Q1 2024 Earnings Presentation
PU
Pacific Biosciences: Q1 Earnings Snapshot
AQ
PacBio Announces First Quarter 2024 Financial Results
PR
NewBiologix Launches Next-Generation Sequencing and Optical Mapping Platform to Drive the Next Wave of Biopharmaceutical Discoveries
AQ
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
PR
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PR
PacBio Grants Equity Incentive Award to New Employee
PR
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
PR
PacBio to Present at Upcoming Investor Conferences
PR
Federal Circuit Affirms Claim Construction And How It Applies
AQ
Pacific Biosciences: Q4 Earnings Snapshot
AQ
PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
PR
Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch
PR
PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PR
PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
PR
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
PR
PacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
PR
PacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action PACB
  4. Action P09
  5. Actualités Pacific Biosciences of California, Inc.
  6. Communiqués